Evidence map›Paper›PMID 33721175›Full record

ArticlePituitary2021

Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study.

Aysa Hacioglu, Aycan Gundogdu, Ufuk Nalbantoglu, Zuleyha Karaca, Muhammed Emre Urhan, Serdar Sahin, Hatice Sebile Dokmetas, Pinar Kadioglu, Fahrettin Kelestimur, Pituitary Microbiom Study Group (PITMIT-SG)

Abstract read
PubMed Publisher
In one paragraph

Article in Pituitary, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Aysa HaciogluDepartment of Endocrinology, School of Medicine, Erciyes University, Kayseri, Turkey.
Aycan GundogduDepartment of Microbiology and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Ufuk NalbantogluGenome and Stem Cell Center (GenKok), Erciyes University, Kayseri, Turkey.
Zuleyha KaracaDepartment of Endocrinology, School of Medicine, Erciyes University, Kayseri, Turkey.
Muhammed Emre UrhanDepartment of Endocrinology, School of Medicine, Erciyes University, Kayseri, Turkey.
Serdar SahinDepartment of Endocrinology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Hatice Sebile DokmetasDepartment of Endocrinology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Pinar KadiogluDepartment of Endocrinology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Fahrettin KelestimurDepartment of Endocrinology, School of Medicine, Yeditepe University, Istanbul, Turkey. fktimur@erciyes.edu.tr.ORCID http://orcid.org/0000-0002-2861-4683
Pituitary Microbiom Study Group (PITMIT-SG)
Erciyes University · TRIstanbul University-Cerrahpaşa · TRIstanbul Medipol University · TRYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMicrobiota has crucial biological importance for human well-being. Bidirectional interaction exists between microbiota and the host, and there have been no studies investigating this interaction in patients with acromegaly. We aimed to analyze the composition of microbiota in patients with newly diagnosed acromegaly.

methodStool samples were obtained from the patients with newly diagnosed acromegaly in the Endocrinology Clinic of Erciyes University Medical School. The composition of microbiota was analyzed, and the results were compared to healthy volunteers matched to the patients in terms of age, gender and body mass index.

resultsSeven patients (three male, four female) with a mean age of 48 ± 17.6 years were included in the study. The stool analysis revealed a significantly lower bacterial diversity in the patients with acromegaly. Bacteroidetes phylum was predominating in the patient group, and Firmicutes/Bacteroidetes ratio was altered significantly. Bifidobacterium, Collinsella, Bacteroides, Butyricimonas, Clostridium, Oscillospira, and Dialister were predominating in the control group.

conclusionThe gut microbiota is significantly altered in patients with newly diagnosed acromegaly. Further prospective studies are needed to elucidate the causative relationship between acromegaly, colorectal pathologies, and microbial alterations.

Indexed as

AcromegalyGastrointestinal MicrobiomeAdultAgedBacteroidetesCross-Sectional StudiesFemaleHumansMaleMiddle AgedAcromegalyBacteroidesGrowth hormoneGut microbiotaInsulin like growth factor-1Pituitary

Identifiers

PMID33721175
OpenAlexW3137233810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.